JFROG LTD (FROG)

IL0011684185 - Common Stock

30.59  -0.11 (-0.36%)

After market: 30.59 0 (0%)

Fundamental Rating

5

Taking everything into account, FROG scores 5 out of 10 in our fundamental rating. FROG was compared to 280 industry peers in the Software industry. No worries on liquidiy or solvency for FROG as it has an excellent financial health rating, but there are worries on the profitability. FROG is valued quite expensively, but it does show have an excellent growth rating.



3

1. Profitability

1.1 Basic Checks

In the past year FROG was profitable.
In the past year FROG had a positive cash flow from operations.
In the past 5 years FROG always reported negative net income.
FROG had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

FROG's Return On Assets of -5.30% is in line compared to the rest of the industry. FROG outperforms 47.99% of its industry peers.
Looking at the Return On Equity, with a value of -7.57%, FROG is in line with its industry, outperforming 52.01% of the companies in the same industry.
Industry RankSector Rank
ROA -5.3%
ROE -7.57%
ROIC N/A
ROA(3y)-8.06%
ROA(5y)-5.56%
ROE(3y)-11.17%
ROE(5y)-7.8%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 77.98%, FROG is doing good in the industry, outperforming 74.36% of the companies in the same industry.
FROG's Gross Margin has been stable in the last couple of years.
FROG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.27%

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FROG has been increased compared to 1 year ago.
Compared to 5 years ago, FROG has more shares outstanding
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

FROG has an Altman-Z score of 6.35. This indicates that FROG is financially healthy and has little risk of bankruptcy at the moment.
FROG has a Altman-Z score of 6.35. This is in the better half of the industry: FROG outperforms 69.96% of its industry peers.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.35
ROIC/WACCN/A
WACC11.46%

2.3 Liquidity

A Current Ratio of 2.03 indicates that FROG has no problem at all paying its short term obligations.
FROG's Current ratio of 2.03 is fine compared to the rest of the industry. FROG outperforms 60.44% of its industry peers.
FROG has a Quick Ratio of 2.03. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
FROG has a better Quick ratio (2.03) than 60.81% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03

7

3. Growth

3.1 Past

FROG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.56%, which is quite impressive.
Looking at the last year, FROG shows a very strong growth in Revenue. The Revenue has grown by 24.45%.
FROG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.68% yearly.
EPS 1Y (TTM)80.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)24.45%
Revenue growth 3Y32.39%
Revenue growth 5Y40.68%
Sales Q2Q%23.04%

3.2 Future

The Earnings Per Share is expected to grow by 18.32% on average over the next years. This is quite good.
The Revenue is expected to grow by 19.38% on average over the next years. This is quite good.
EPS Next Y19.86%
EPS Next 2Y15.22%
EPS Next 3Y16.78%
EPS Next 5Y18.32%
Revenue Next Year23.4%
Revenue Next 2Y20.21%
Revenue Next 3Y19.11%
Revenue Next 5Y19.38%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

FROG is valuated quite expensively with a Price/Earnings ratio of 47.06.
Compared to the rest of the industry, the Price/Earnings ratio of FROG indicates a somewhat cheap valuation: FROG is cheaper than 62.27% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, FROG is valued quite expensively.
With a Price/Forward Earnings ratio of 45.18, FROG can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FROG is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, FROG is valued quite expensively.
Industry RankSector Rank
PE 47.06
Fwd PE 45.18

4.2 Price Multiples

FROG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FROG is cheaper than 71.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.39
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as FROG's earnings are expected to grow with 16.78% in the coming years.
PEG (NY)2.37
PEG (5Y)N/A
EPS Next 2Y15.22%
EPS Next 3Y16.78%

0

5. Dividend

5.1 Amount

FROG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JFROG LTD

NASDAQ:FROG (1/3/2025, 8:00:01 PM)

After market: 30.59 0 (0%)

30.59

-0.11 (-0.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-12 2025-02-12/amc
Inst Owners74.1%
Inst Owner Change7.51%
Ins Owners19.37%
Ins Owner Change-2.64%
Market Cap3.41B
Analysts81.48
Price Target37.44 (22.39%)
Short Float %2.88%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)2.88%
Max EPS beat(2)39.08%
EPS beat(4)4
Avg EPS beat(4)25.1%
Min EPS beat(4)2.88%
Max EPS beat(4)49.47%
EPS beat(8)8
Avg EPS beat(8)64.6%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)1.25%
Revenue beat(4)2
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)2.49%
Revenue beat(8)2
Avg Revenue beat(8)-0.39%
Revenue beat(12)4
Avg Revenue beat(12)-0.03%
Revenue beat(16)6
Avg Revenue beat(16)-0.1%
PT rev (1m)0%
PT rev (3m)5.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.29%
EPS NY rev (1m)0%
EPS NY rev (3m)7.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 47.06
Fwd PE 45.18
P/S 8.33
P/FCF 37.39
P/OCF 36.15
P/B 4.51
P/tB 10.73
EV/EBITDA N/A
EPS(TTM)0.65
EY2.12%
EPS(NY)0.68
Fwd EY2.21%
FCF(TTM)0.82
FCFY2.67%
OCF(TTM)0.85
OCFY2.77%
SpS3.67
BVpS6.78
TBVpS2.85
PEG (NY)2.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.3%
ROE -7.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.98%
FCFM 22.28%
ROA(3y)-8.06%
ROA(5y)-5.56%
ROE(3y)-11.17%
ROE(5y)-7.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.27%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 17.02%
Cap/Sales 0.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z 6.35
F-Score6
WACC11.46%
ROIC/WACCN/A
Cap/Depr(3y)33.24%
Cap/Depr(5y)51.99%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y19.86%
EPS Next 2Y15.22%
EPS Next 3Y16.78%
EPS Next 5Y18.32%
Revenue 1Y (TTM)24.45%
Revenue growth 3Y32.39%
Revenue growth 5Y40.68%
Sales Q2Q%23.04%
Revenue Next Year23.4%
Revenue Next 2Y20.21%
Revenue Next 3Y19.11%
Revenue Next 5Y19.38%
EBIT growth 1Y-2.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year114.28%
EBIT Next 3Y48.87%
EBIT Next 5YN/A
FCF growth 1Y238.16%
FCF growth 3Y40.65%
FCF growth 5Y67.46%
OCF growth 1Y197.14%
OCF growth 3Y36.03%
OCF growth 5Y54%